SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-18-042979
Filing Date
2018-02-14
Accepted
2018-02-13 17:44:03
Documents
2
Group Members
LIAM RATCLIFFENEW LEAF VENTURE ASSOCIATES I, L.P.NEW LEAF VENTURE MANAGEMENT I, L.L.C.RONALD HUNTVIJAY LATHI

Document Format Files

Seq Description Document Type Size
1 SC 13G d445787dsc13g.htm SC 13G 112727
2 EX-99.1 d445787dex991.htm EX-99.1 11336
  Complete submission text file 0001193125-18-042979.txt   125804
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Subject) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-83379 | Film No.: 18605398
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address 7 TIMES SQUARE SUITE 1603 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 1603 NEW YORK NY 10036 646-871-6400
New Leaf Ventures I, L.P. (Filed by) CIK: 0001375661 (see all company filings)

IRS No.: 260137799 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G